Production (Stage)
Repare Therapeutics Inc.
RPTX
$1.37
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.67% | 1.06% | -364.20% | 146.96% | -48.47% |
| Total Depreciation and Amortization | -5.02% | -2.05% | -2.59% | -0.99% | 1.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.91% | -16.42% | -6.10% | 9.57% | 4.13% |
| Change in Net Operating Assets | -230.53% | 30.78% | 78.05% | -27.17% | 69.82% |
| Cash from Operations | 10.53% | -0.08% | -355.73% | 142.38% | 14.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.63% | 336.64% | 135.04% | -162.94% | 31.75% |
| Cash from Investing | 1.63% | 336.64% | 135.04% | -163.73% | 30.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.40% | -- | -100.00% | 257.14% | -63.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.40% | -- | -100.00% | 257.14% | -63.03% |
| Foreign Exchange rate Adjustments | -721.43% | 1,500.00% | 97.62% | -159.15% | 181.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 479.20% | 103.08% | -190.61% | -306.49% | 147.69% |